Announce Date | 02/05/2025 |
EPS Normalized Actual | $3.41 (Beat by $0.45) |
EPS GAAP Actual | $3.41 (Beat by $0.45) |
Revenue Actual | $11.669B |
Revenue Surprise | Beat by $11669M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Sep 2029 | 14.06 | 9.07 | 13.32472 | 14.84659 | 3 |
Sep 2028 | 14.06 | 9.07 | 13.22512 | 14.8902 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 2.86 | 2.86 | 11.669B | 14.86% | 11669M |
FQ3 2024 (Sep 2024) | 2.62 | 2.62 | 10.244B | 15.75% | 10244M |
FQ2 2024 (Jun 2024) | 1.91 | 1.91 | 9.393B | 10.03% | 9393M |
FQ1 2024 (Mar 2024) | 2.08 | 2.08 | 9.389B | 1.21% | 9389M |
FQ4 2023 (Dec 2023) | 2.48 | 2.48 | 9.935B | 4.75% | 9935M |
FQ3 2023 (Sep 2023) | 1.33 | 1.33 | 8.631B | -32.04% | 8631M |
FQ2 2023 (Jun 2023) | 1.62 | 1.62 | 8.451B | -29.4% | 8451M |
FQ1 2023 (Mar 2023) | 1116 | 1116 | 9.275B | 100% | 9275M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Sep 2028) | 2.93 | -- | 2.80405 | 3.0281 | 13 |
FQ2 2028 (Jun 2028) | 2.9 | -- | 2.77534 | 2.99709 | 8 |
FQ1 2028 (Mar 2028) | 2.89 | -- | 2.76577 | 2.98676 | 8 |
FQ4 2027 (Dec 2027) | 3.06 | -- | 2.92847 | 3.16245 | 7 |
FQ3 2027 (Sep 2027) | 4.06 | -- | 4.06 | 4.06 | 7 |
FQ2 2027 (Jun 2027) | 3.92 | -- | 3.92 | 3.92 | 8 |
FQ1 2027 (Mar 2027) | 3.66 | -- | 3.66 | 3.66 | 14 |
FQ4 2026 (Dec 2026) | 4.49 | -- | 4.49 | 4.49 | 9 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Sep 2028) | 11.38B | -- | 11.01B | 11.68B | 12 |
FQ2 2028 (Jun 2028) | 11.23B | -- | 10.86B | 11.52B | 12 |
FQ1 2028 (Mar 2028) | 10.94B | -- | 10.57B | 11.22B | 12 |
FQ4 2027 (Dec 2027) | 10.9B | -- | 10.54B | 11.18B | 7 |
FQ3 2027 (Sep 2027) | 12.6B | -- | 12.6B | 12.6B | 8 |
FQ2 2027 (Jun 2027) | 12.4B | -- | 12.4B | 12.4B | 9 |
FQ1 2027 (Mar 2027) | 11.4B | -- | 11.4B | 11.4B | 15 |
FQ4 2026 (Dec 2026) | 13.4B | -- | 13.4B | 13.4B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 2.86 | 2.86 | 100% | |
FQ3 2024 (Sep 2024) | 2.62 | 2.62 | 100% | |
FQ2 2024 (Jun 2024) | 1.91 | 1.91 | 100% | |
FQ1 2024 (Mar 2024) | 2.08 | 2.08 | 100% | |
FQ4 2023 (Dec 2023) | 2.48 | 2.48 | 100% | |
FQ3 2023 (Sep 2023) | 1.33 | 1.33 | 100% | |
FQ2 2023 (Jun 2023) | 1.62 | 1.62 | 100% | |
FQ1 2023 (Mar 2023) | 1116 | 1116 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $11.67B | $11669M | 100% |
FQ3 2024 (Sep 2024) | $0B | $10.24B | $10244M | 100% |
FQ2 2024 (Jun 2024) | $0B | $9.39B | $9393M | 100% |
FQ1 2024 (Mar 2024) | $0B | $9.39B | $9389M | 100% |
FQ4 2023 (Dec 2023) | $0B | $9.94B | $9935M | 100% |
FQ3 2023 (Sep 2023) | $0B | $8.63B | $8631M | 100% |
FQ2 2023 (Jun 2023) | $0B | $8.45B | $8451M | 100% |
FQ1 2023 (Mar 2023) | $0B | $9.28B | $9275M | 100% |